Unusual KRAS mutation in pancreatic cancer may explain less aggressive tumors
A study led by Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D., at MUSC Hollings Cancer Center, reveals why a specific gene mutation behaves differently from other variants.
Jan 20, 2026
0
32









